Yosef Ellenbogen
@YosefEllenbogen
Followers
375
Following
501
Media
1
Statuses
40
University of Toronto | Neurosurgery Resident
Joined January 2011
RT @NSTumorSection: 🧠 Headed to CNS 2025 in LA?.🔥 Join the Tumor Section for the ultimate networking event!.🎯 Resident Meet & Greet w/ Fell….
0
9
0
RT @AANSNeuro: Join the @NSTumorSection for a live webinar on the latest in neurosurgical tumor care—featuring expert insights and timely u….
0
4
0
RT @AANSNeuro: Deadline Extended!. Neuro-oncology trainees & early-career neurosurgeons: Submit your abstract for the @NSTumorSection Limel….
0
3
0
RT @AANSNeuro: Calling all neuro-oncology trainees and early-career neurosurgeons! Submit your research for the Limelight Webinar, hosted b….
0
3
0
RT @AANSNeuro: Calling all neuro-oncology trainees and early-career neurosurgeons! Submit your research for the Limelight Webinar, hosted b….
0
13
0
RT @ap_landry: Our new paper is out today in @JAMAOnc demonstrating the importance of chromosome 1p loss and 1q gain in #meningioma grading….
jamanetwork.com
This cohort study examines chromosomal copy number alterations that could be used to improve the current World Health Organization grading of meningioma.
0
14
0
RT @NatureMedicine: Lessons from a detailed case report reveal avenues for research into #neoadjuvant combination #immunotherapy in newly d….
nature.com
Nature Medicine - A detailed case report shows that neoadjuvant combination immunotherapy can activate antitumor immunity and drive clinical benefit in newly diagnosed glioblastoma, revealing...
0
14
0
RT @DrFehlings: I was pleased to host a University of Toronto Department of Surgery Career Planning evening for our trainees at the Faculty….
0
2
0
We hope this commentary provides the opportunity to reflect on this important work and its implications for the future of glioblastoma research. #glioblastoma #immunotherapy #neurooncology.
1
0
3
Grateful to @ProfGLongMIA , @ProfRAScolyer & team for their exciting contribution - made even more powerful through true patient partnership. Original study: Our commentary:
nature.com
Nature Medicine - A detailed case report shows that neoadjuvant combination immunotherapy can activate antitumor immunity and drive clinical benefit in newly diagnosed glioblastoma, revealing...
1
0
8
RT @NSTumorSection: Don’t miss the inaugural Limelight Research Lab Webinar on April 10, 2025! . Submit your papers now . April 10, 2025 |….
0
4
0
RT @gelarehzadeh: We invite you to submit your research abstract for presentation @NSTumorSection @AANSNeuro .Lab Meeting style review of r….
0
6
0
RT @NSTumorSection: Excited to announce this huge opportunity!.Submit abstract and letter of interest as faculty: limelight.webinar@gmail.c….
0
6
0
RT @gelarehzadeh: The pillars @NASBSorg .Taking it all in @YosefEllenbogen @ap_landry @lsyefet .#skullbase #NASBS2025 .@MayoClinic @MayoCli….
0
9
0
RT @gelarehzadeh: The third in a row of publications on #meningioma @ap_landry @ICOMeningioma .Metabolic profiling, routine #HPLC for bioma….
0
9
0
RT @FarshadNassiri: Read these short summaries of amazing research articles published in @EditorNeuro . We are committed to making brain tu….
0
8
0
RT @RobSpinnerMD: @exciting advances in brain tumors by @gelarehzadeh. So many opportunities for peripheral nerve tumors. Stay tuned. ….
0
5
0
RT @justinzw: Glad to present our comprehensive state of the field review on meningiomas in @NeuroOnc made possible through key contributio….
academic.oup.com
Abstract. Meningiomas are the most common primary intracranial tumors in adults and are increasing in incidence due to the aging population and increased a
0
12
0
RT @gelarehzadeh: Big News! .I am proud to be #EditorInChief of 'my' Journal & Editorial Team!! .Fantastic Impact Factor Increase to 3.7 .W….
0
21
0
RT @UofTNeuroSurge: Inviting all Medical Students to join us to learn more about our program.@UofTNeuroSurge @UofTSurgery @uoftmedicine .@U….
0
4
0